Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | the enzyme activity is positively correlated with nitric oxide and cGMP levels in cavernous tissue, overview | Rattus norvegicus | |
sildenafil | - |
Rattus norvegicus | |
tadalafil | - |
Rattus norvegicus | |
vardenafil | - |
Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Zn protoporphyrin | - |
Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
heme + AH2 + O2 | Rattus norvegicus | heme degradation | biliverdin + Fe2+ + CO + A + H2O | - |
? | |
additional information | Rattus norvegicus | the enzyme activity is positively correlated with nitric oxide and cGMP levels in cavernous tissue, overview | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
male sprague-dawley rats | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cavernous artery | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.000015 | - |
cavernous tissue of sildenafil-treated rats | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
heme + AH2 + O2 | - |
Rattus norvegicus | biliverdin + Fe2+ + CO + A + H2O | - |
? | |
heme + AH2 + O2 | heme degradation | Rattus norvegicus | biliverdin + Fe2+ + CO + A + H2O | - |
? | |
additional information | the enzyme activity is positively correlated with nitric oxide and cGMP levels in cavernous tissue, overview | Rattus norvegicus | ? | - |
? |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Rattus norvegicus |